OSTEOARTHRITIS: THE CURRENT STATE OF THE PROBLEM

Download full text PDF
Issue: 
10
Year: 
2016

Professor A. Vlasenko, MD S.M. Kirov Military Medical Academy, Saint Petersburg

The paper analyzes Russian and foreign literature on current ideas about the etiology, pathogenesis, clinic presentations, and therapy of osteoarthritis.
Keywords: 
rheumatology
osteoarthritis
chondrocytes
cartilage
symptommodifying and structure-modifying drugs

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Alekseeva L.I. Osteoartroz. V kn.: Revmatologija: natsional'noe rukovodctvo. Pod red. E.L. Nasonova, V.A. Nasonovoj / M.: GEOTAR-Media, 2008; c. 573–89.
  2. EULAR Compedium in Rheumatic Disease. Ed. J. Bijsma / BMJ, 2009; 824.2.
  3. Jashina E. Preparaty gialuronovoj kisloty v lechenii osteoartroza // Vrach. – 2015; 2; 58–61.
  4. Smith M., Ghosh P. Osteoarthritis: Current status and future directions // APLAR J. Rheum. – 1998; 2: 27–63.
  5. Meshkov A.P. Osteoartoz. V kn.: Diagnostika i lechenie boleznej susta vov / N. Novgorod: Izd-vo NGMA, 2000; s. 133–47.
  6. Alekseeva L.I. Osteoartroz ili osteoartrit? Sovremennye predstav lenija o bolezni i ee lechenii // Effektivnaja farmakoterapija. Revmatologija. Travmatologija i ortopedija. – 2014; 2: 32–3.
  7. Hitrov N.A. Osteoartroz ili osteoartrit – ot novyh vzgljadov v patoge neze k novomu nazvaniju // Meditsinskij sovet. – 2013; 4: 74–8.
  8. Pjaj L.T. Osnovy klinicheskoj revmatologii / Tallin, Valgus, 1987; s. 6–15.
  9. National Clinical Guideline Centre Osteoarthritis. Care and management in adults London (UK). National institute for Health and Care Exellense (NICE) // Clin. Guideline. – 2014; 177: 556.
  10. Mazurov V.I., Onuschenko I.A. Osteoartroz. V kn.: Klinicheskaja revma tologija. Pod red. V.I. Mazurova. 2-e izd. Pererab. i dop. / SPb: OOO Izdatel'stvo FOLIANT, 2005; s. 386–408.
  11. Badokin V.V. Sovremennye aspekty patogeneticheskoj terapii osteo artroza // Meditsinskij sovet. – 2013; 12: 77–81.
  12. Svetlova M.S. Patogeneticheskoe lechenie osteoartroza kolennyh sustavov // Sovr. revmatologija. – 2012; 3: 44–9.
  13. Currey H. Osteoartroz. V kn.: Klinicheskaja revmatologija: Per s angl. Pod red. N. Currey. / M.: Meditsina, 1990; s. 121–36.
  14. Balobanova R.M. Novye podhody k lecheniju osteoartroza kak hroniche skogo vospalitel'nogo zabolevanija // Sovrem. revmatol. – 2013; 2: 95–8.
  15. Roux C., Saraux A., Mazieres B. et al. Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates // Ann. Rheum. Dis. – 2008; 67 (10): 1406–11.
  16. Blagoejevic M., Jinks C., Jeffery A. et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis // Osteoarthritis Cartilage. – 2010; 18 (1): 24–33.
  17. Solovieva S., Kocmarainen O., Hirvonen A. et al. Association between interleukin-1 gene cluske polymorphisms and bilateral distol interhalangeol osteoarthritis // J. Rheum. – 2009; 36: 1977–8.
  18. Calich A., Domiciano D., Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment? // J. Clin. Rheumatol. – 2010; 29 (5): 451–5.
  19. Lim W., Toothman J., Miller J. et al. IL-1 beta inhibits TGF-beta in the temporomandibular joint // J. Dent. Res. – 2009; 88 (6): 557–62.
  20. Balobanova R.M. Rol' interlejkina-1 pri osteoartroze i vozmozhno sti ego blokirovaija // Sovrem. revmatol. – 2011; 1: 58–62.
  21. Shirokova L., Mokrousova M., Simionova S. i dr. Osteoartroz: kontseptsii i rol' metabolicheskih narushenij v povrezhdenii sustav-nyh komponentov // Vrach. – 2013; 10: 8–10.
  22. Connaghan P., Vanharanta H., Dieppe P. Is progressive osteoarthritis an atheromatous vascular disease? // Ann. Rheum. Dis. – 2005; 64: 1539–41.Kellgren J., Lawrence J. Radiological assessment of osteoarthrosis // Ann. 23. Rheum. Dis. – 1957; 16: 494–501.
  23. Benevolenskaja L.I., Alekseeva L.I. Diagnosticheskie kriterii osteo artroza. Sovremennye problemy revmatologii. Tez. dokladov I s'ezda revma-tologov Rossii / Orenburg, 1993; s. 191–2.
  24. Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee // Art. Rheum. – 1986; 29 (8): 1039–40.
  25. Altman R., Alarcon G., Appelrauth D. et al. The American College of . Rheumatology criteria for the classification and reporting of osteoarthritis of the hand // Art. Rheum. – 1990; 33: 1601–10.
  26. Altman R., Alarcon G., Appelrauth D. et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip // Art. Rheum. – 1991; 34: 505–14.
  27. Svetlova M.S. Podhody k lecheniju osteoartroza kolennyh sustavov na rannih stadijah zabolevanija // Meditsinskij sovet. – 2012; 2: 61–6. Alekseeva L.I. Rekomendatsii po lecheniju osteoartroza. Pod red. E.L. Nasonova / M.: GEOTAR-Media, 2010; 15 s.
  28. Karateev A.E. Farmakoterapija osteoartroza: otnoshenie pol'zy i riska // Effektivnaja farmakoterpija. Revmatologija. Travmatologija i orto-pedija. – 2014; 2: 22–4.
  29. Goncharov N.A. Lokal'naja terapija osteoartroza NPVS s chrezkozhnym mehanizmom vvedenija // Meditsinskij sovet. – 2011; 7–8; 53–7.
  30. Rosin G., Barbieri C., Lancas F. Diclofenac phonophoresis in human vol unteers // Ultrasound Med. Viol. – 2005; 31: 337–43.
  31. Alekseeva L.I. Mesto lokal'noj terapii v lechenii osteoartroza // 33. Meditsinskij sovet. – 2011; 7–8: 45–8.
  32. Nanda A., Nanda S., Khan Gnilrai N. Current Developments using emerging Transdermal Technologies in physical enhancenment methods // Curr. Drag. Deliv. – 2006; 3: 23–34.
  33. Drozdov V.N. Novyj preparat Zinaksin v lechenii osteoartroza // Rus. med. zhurnal. – 2008; 16 (4): 190–1.
  34. Altman R., Marcussen K. Effects of a ginger extract on knee in patients with osteoarthritis // Arthritis Rheum. – 2011; 44 (11): 2531–8.
  35. Briddel H., Rozetzsky A., Schlichting R. et al. A randomized placebo controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis // Osteoarthr. Cartil. – 2000; 8: 9–12.
  36. Tsvetkova E.S, Denisov L.N. Simptomaticheskaja terapija osteoartroza 38. kolennyh sustavov – novye vozmozhnosti // Nauchno-prakt. revmatol. – 2011; 6: 42–5.
  37. Solomon D., Rassen J., Glynn R. et al. The comparative safety of 39. analgesios in older adults with arthritis // Arch. Intern. Med. – 2010; 170 (22): 1968–76.
  38. Lesnjak O.M., Maksimov D.M., Popov A.A. i dr. Osteoartroz: medika-40. mentoznoe lechenie osteoartroza (osteoartrita) kolennyh i tazobedrennyh sustavov // Consilium Medicum. – 2005; 7 (8): 627–33.
  39. Beljaeva I.B. Sovremennaja farmakoterapija osteoartroza // 41. Effektivnaja farmakoterapija. Revmatologija. Travmatologija i ortope-dija. – 2015; 2; 20–4.
  40. Burmakova G.M., Savchenko A.M. Vnutrisustavnaja ozonoterapija v lechenii osteoartroza // Meditsinskij sovet. – 2011; 7–8: 35–8.
  41. Idov I.E. Aspekty primenenija ozona v meditsine // Anest. i renima tol. – 1997; 1: 90–4.
  42. Lohmander L. Markers of cartilage metabolism in arthrosis // Acta Orthop. Scand. – 1991; 2: 623–32.
  43. Pincus T. Clinical evidence for osteoarthritis as an inflammatory disease // Curr. Rheum. Rep. – 2001; 3: 524–34
  44. Anikin S.G., Alekseeva L.I. Primenenie preparatov gialuronovoj kisloty pri osteoartroze kolennyh sustavov // Nauchno-prakt. revmatol. – 2013; 51 (4): 439–45.
  45. Wang C., Lin J., Chang C. et al. Therapeutic effects of hyaluronic acid on 47. osteoarthritis of the knee. A metaanalysis of randomized controlled trials // J. Bone Jt. Surg. – 2004; 86A (3): 538–45.
  46. Mihalina M., Men'shikova I., Sulimov V. Primenenie preparatov 48. gialuronovoj kisloty u patsientov s osteoartrozom kolennyh sustavov // Vrach. – 2010; 5: 61–4.
  47. Kemper F., Gebhardt U., Meng T. et al Tolerabiliti and short-term 49. effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice // Curr. Med. Res. Opin. – 2005; 21 (8): 1261–9.
  48. Solov'eva I., Shesternja N., Perova N. i dr. Kombinirovannoe prime-50. nenie biopolimernogo gidrogelja i gialuronovoj kisloty pri osteoartroze (pervyj opyt) // Vrach. – 2016; 1: 12–7.
  49. Lygina E.V. Hondroprotektory v lechenii osteoartroza // Sovr. revma-51. tologija. – 2012; 2: 59–64.
  50. Vertkin A.L., Talibov O.B Lechenie osteoartroza: rol' hondroprotek-52. torov // Lechaschij vrach. – 2000; 9: 40
  51. Lukina G.V., Sigidin Ja.A. Alflutop v lechenii osteoartroza // Nauchno-53. prakt. revmatol. – 2001; 2: 51
  52. Svetlova M.S., Ignat'ev V.K. Primenenie alflutopa v lechenii bol'-54. nyh osteoartrozom // Klin. meditsina. – 2004; 5: 52–5.
  53. Kahan A. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee 55. osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-con-trolled trial // Arthritis Rheum. – 2009; 60 (2): 524–33.
  54. McAlindon T., LaValley M., Gulin J. et al. Glucozamine and chondroitin for 56. treatment of osteoarthritis a systematic quality assessment and meta-analysis // JAMA. – 2000; 283 (11): 1469–75.
  55. Pavelca K., Gatterova J., Olejarova M. et al. Glucosamine sulfate use and 57. delay of progression of knee osteoarthritis: a 3-years randomized, placebo-controlled, double-blind study // Arch. Intern. Med. – 2002; 162 (18); 213–23.
  56. Noskov S., Lavruhina A., Shirokova K. i dr. Strategija primenenija 58. hondroprotektorov pri osteoartroze // Vrach. – 2012; 10: 14–5.
  57. Alekseeva L.I., Koshevarova N.G., Sharapova E.P. i dr. Sravnenie 59. postojannogo i intermittirujuschego lechenija bol'nyh osteoartrozom kolen-nyh sustavov kombinirovannym preparatom Terafleks // Nauchno-prakt. rev-matol. – 2008; 3: 68–72.
  58. Sharapova E.P., Alekseeva L.I. Kombinirovannye simptomaticheskie 60. preparaty zamedlennogo dejstvija v terapii osteoartroza // Rus. med. zhur-nal – 2009; 17 (3): 160–5.
  59. Burkhard F. Leeb. Clinical Efficacy and Safety of Diacerein in 61. Osteoarthritis. – A Review // Eur. Musculoskeletiol. Rev. – 2010; 5 (1): 23–9.
  60. Dougados M., Nguyen M., Berdah L. et al. Evaluation of the structure 62. modifying effects of diacerein in hip osteoarthritis: ECHODIAN a three-year placebo-controlled trial Evalution of the Chondromodulation Effects of Diacerein in osteoarthritis of the hip // Arthritis Rheum. – 2001; 44 (11): 2539–47.
  61. Alekseeva L.I., Chichasova N.V., Koshevarova N.G. i dr. Primenenie 63. piaskledina pri osteoartroze kistej // Farmateka. – 2010; 10: 48–55.
  62. Chichasova N.V., Alekseeva L.I., Badokin V.A. i dr. Opyt primenenija neomyljaemyh soedinenij avokado i bobov soi (Piaskledin) v lechenii osteoartroza razlichnoj lokalizatsii // Rus. med. zhurnal. – 2014; 6: 1–19.
  63. Henrotin Y., Sanchez C., Deberg M. et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteo-arthritis chondrocytes // J. Rheumatol. – 2003; 30: 1825–34.
  64. Altinel L., Soritas Z., Kose K. et al. Treatment with unsaponifiable extracts 66. of avocado and soybean increases TGF-beta 1 and TGF-beta 2 levels in canine joint fluid // Tohoku J. Exp. Med. – 2007; 211 (2): 181–6.
  65. Zborovskij A.B., Stazharov M.Ju., Mozgovaja G.E. Sistemnaja enzimote rapija v lechenii revmaticheskih zabolevanij // Nauchno-prakt. revmatol. – 2003; 1: 64–9.
  66. Alekseeva L.I., Zajtseva L.M. Perspektivnye napravlenija terapii osteoartroza // Nauchno-prakt. revmatol. – 2014; 3: 247–50.